SCHEMBL5370592

SCHEMBL5370592

COC(=O)c1cc(S(=O)(=O)Nc2ccc(SCc3cccc(C(F)(F)F)c3)cc2)cc(C)c1C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B2 P37059 1/20 0.43
MAPT P10636 4/20 0.43
HTT P42858 4/20 0.43
NPSR1 Q6W5P4 4/20 0.43
TP53 P04637 2/20 0.43
LMNA P02545 2/20 0.43
MEN1 O00255 1/20 0.43
POLB P06746 1/20 0.43
XBP1 P17861 1/20 0.43
ALOX12 P18054 1/20 0.43
KMT2A Q03164 1/20 0.43
HIF1A Q16665 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
HPGD P15428 2/20 0.42
GAA P10253 1/20 0.42
CYP1A2 P05177 2/20 0.41
CYP3A4 P08684 2/20 0.41
CYP2C9 P11712 2/20 0.41
CYP2C19 P33261 2/20 0.41
SERPINE1 P05121 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5375344 0.91 HSD17B2 (0.45) HSD17B2MAPTHTTNPSR1TP53
SCHEMBL5380333 0.89 HDAC3 (0.47) HTTNPSR1LMNAPOLBSERPINE1
SCHEMBL5376424 0.84 HTT (0.52) MAPTHTTNPSR1TP53LMNA
SCHEMBL5382118 0.84 HDAC1 (0.46) MAPTHTTNPSR1TP53LMNA
SCHEMBL5367820 0.83 POLB (0.51) HSD17B2MAPTHTTNPSR1TP53
SCHEMBL5391352 0.82 POLB (0.47) HSD17B2MAPTHTTNPSR1MEN1
SCHEMBL5386755 0.82 HDAC3 (0.47) MEN1POLBKMT2ASERPINE1IDH1
SCHEMBL5368417 0.80 ALOX15 (0.48) HSD17B2MAPTHTTNPSR1MEN1
SCHEMBL5921903 0.79 HDAC3 (0.50) HTTNPSR1LMNAPOLBKMT2A
SCHEMBL5391308 0.77 HDAC1 (0.46) POLBSERPINE1IDH1ALDH1A1FFAR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PFIZER INC 2006-11-16 US disclosed
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD HSD17B2 972/4885MAPT 1786/4885HTT 696/4885
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARG, PPARA, PPARD HSD17B2 1220/4885MAPT 1984/4885HTT 894/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.